MKI67 and neoplasm: In summary, baseline patient characteristics were similar between both treatment arms: mean age was 64 years, mean tumor size was 3.8 cm, clinical node-positive disease represented 39.0%, and the mean Ki67 by immunohistochemistry (IHC) was 33.2%.